Efficacy and safety of vardenafil in men with erectile dysfunction and depression.
- Author:
Liquan HU
1
Author Information
1. Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China. huliquan0202@sina.com
- Publication Type:Clinical Trial
- MeSH:
Adult;
Aged;
Aged, 80 and over;
Depressive Disorder;
complications;
drug therapy;
Erectile Dysfunction;
complications;
drug therapy;
Humans;
Imidazoles;
adverse effects;
therapeutic use;
Male;
Middle Aged;
Phosphodiesterase Inhibitors;
adverse effects;
therapeutic use;
Piperazines;
adverse effects;
therapeutic use;
Quality of Life;
Sulfones;
adverse effects;
therapeutic use;
Treatment Outcome;
Triazines;
adverse effects;
therapeutic use;
Vardenafil Dihydrochloride
- From:
National Journal of Andrology
2004;10(11):876-879
- CountryChina
- Language:Chinese
-
Abstract:
Erectile dysfunction (ED) usually exists in combination with depression in men. The comorbidity of the two diseases may bring more troubles to patients, so it is important to find an effective treatment. Recently, DRIVER (Depression Related Improvement with Vardenafil for Erectile Response) trials showed that, phosphodiesterase 5 (PDE 5) inhibitor vardenafil could improve not only erectile function but also depressive symptoms and quality of life in men with ED and depression. Vardenafil was generally safe and well tolerated.
